Denmark Raises Growth Forecast on Novo Nordisk Wegovy Pill Success
Denmark has raised its 2026 economic growth forecast for the fourth time, with Novo Nordisk's weight-loss pill Wegovy playing a significant role in the upward revision. The pharmaceutical company's new oral medication is providing a larger-than-expected economic boost to the Danish economy, demonstrating the substantial impact of major pharmaceutical innovations on national GDP projections.
Readers say
How does this story lean?
Outlet ratings above are Trace's curated source map. Vote here (same as on the home feed) — one vote per browser, changeable anytime. Rate individual outlets in the coverage list below.
Comments
0No comments yet. Say what you noticed in the coverage.
Trending